ModelEdge
Scinai Immunotherapeutics Ltd
SCNI
Filing type
10-K
Filing date
Apr 16, 2023
Updated
Apr 17, 2023 ยท 10:06 AM

Filing

10-KFY 2022

Exhibits

EX-3.1ARTICLES OF ASSOCIATION OF BIONDVAX PHARMACEUTICALS LTDEX-4.1DESCRIPTION OF SECURITIESEX-10.8ADDENDUM TO EMPLOYMENT AGREEMENT DATED MAY 28, 2015, BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND DR. TAMAR-BEN YEDIDIAEX-10.9ADDENDUM TO EMPLOYMENT AGREEMENT DATED APRIL 1, 2012, BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND DR. TAMAR-BEN YEDIDIAEX-10.10EMPLOYMENT AGREEMENT DATED SEPTEMBER 5, 2018, BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND ELAD MARKEX-10.21AMENDMENT AGREEMENT DATED AUGUST 9, 2022, TO FINANCE CONTRACT DATED JUNE 19, 2017 AND AS AMENDED FROM TIME TO TIME, BY AND BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND THE EUROPEAN INVESTMENT BANKEX-14.1CODE OF CONDUCTEX-23.1CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER OF ERNST & YOUNG GLOBAL, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE REGISTRANTEX-31.1CERTIFICATIONEX-31.2CERTIFICATIONEX-32.1CERTIFICATIONEX-32.2CERTIFICATIONGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic